Melatonin immunoreactivity of epidermal skin is higher in the evening than morning but does not account for erythema sensitivity.

Ultraviolet radiation circadian clock circadian rhythms erythema immunohistochemistry melatonin skin

Journal

Chronobiology international
ISSN: 1525-6073
Titre abrégé: Chronobiol Int
Pays: England
ID NLM: 8501362

Informations de publication

Date de publication:
02 2023
Historique:
medline: 3 5 2023
pubmed: 29 12 2022
entrez: 28 12 2022
Statut: ppublish

Résumé

The skin is a site of melatonin synthesis, and melatonin has a role in protecting against ultraviolet radiation-induced damage. Ultraviolet B (UVB) induced erythema seems to vary between morning and evening. We investigated whether epidermal melatonin immunoreactivities in the morning differed from those in the evening, and whether UVB-induced erythema was associated with these melatonin immunoreactivities in healthy volunteers. Erythema sensitivity of the skin was determined in the morning and in the evening by scoring the Minimal Erythema Dose and quantifying the erythema index (EI). We took biopsies from the non-UVB-exposed skin of healthy volunteers (n = 39) in the morning and in the evening to study melatonin immunoreactivity with immunohistochemistry (IHC). In the IHC staining, there was more melatonin immunoreactivity in the evening than in the morning (

Identifiants

pubmed: 36576151
doi: 10.1080/07420528.2022.2157733
doi:

Substances chimiques

Melatonin JL5DK93RCL

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

132-144

Auteurs

Veera Nikkola (V)

Faculty of Medicine and Health Technology, Department of Dermatology and Venereology, Tampere University, Tampere, Finland.
Department of Dermatology and Allergology, Tampere University Hospital, Tampere, Finland.
Department of Dermatology and Allergology, Päijät-Häme Social and Health Care Group, Lahti, Finland.

Riitta Huotari-Orava (R)

Faculty of Medicine and Health Technology, Department of Pathology and FIMLAB, Tampere University, Tampere, Finland.

Heli Joronen (H)

Faculty of Medicine and Health Technology, Department of Dermatology and Venereology, Tampere University, Tampere, Finland.
Department of Dermatology and Allergology, Tampere University Hospital, Tampere, Finland.
Department of Dermatology and Allergology, Päijät-Häme Social and Health Care Group, Lahti, Finland.

Mari Grönroos (M)

Faculty of Medicine and Health Technology, Department of Dermatology and Venereology, Tampere University, Tampere, Finland.
Department of Dermatology and Allergology, Päijät-Häme Social and Health Care Group, Lahti, Finland.

Hannu Kautiainen (H)

Unit of Primary Health Care, Department of General Practice, Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland.
Unit of Primary Health Care, Kuopio University, Kuopio, Finland.

Lasse Ylianttila (L)

Non-Ionizing Radiation Surveillance, Radiation and Nuclear Safety Authority (STUK), Helsinki, Finland.

Erna Snellman (E)

Faculty of Medicine and Health Technology, Department of Dermatology and Venereology, Tampere University, Tampere, Finland.
Department of Dermatology and Allergology, Tampere University Hospital, Tampere, Finland.
Department of Dermatology, University of Turku, Turku, Finland.

Timo Partonen (T)

Department of Public Health, Finnish Institute for Health and Welfare (THL), Helsinki, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH